UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Before starting a small business, it's crucial to know what you need. This guide outlines the essential tools and resources for success.
22,606 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
The pdsb 2025 earnings call is more than a quarterly update. This guide breaks down what to watch, how to interpret g...
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
When cloud stocks tumble, two giants stand out as potential bargains. This guide breaks down whether Oracle or Salesf...
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
An ex-White House official argues that Washington opened Pell Grants to welding training but buried the plan in an 85...
A strategic partnership sparked a one-day wave for ServiceNow, lifting the stock and focus on future growth. This art...
Cross-border investing in Europe can be tricky because taxes are taken at the source. This guide explains how withhol...
Investors are eyeing OneSpan’s 2025 earnings as the company scales its digital identity and security solutions. This ...
Okta stock popped today after the company highlighted an AI-focused growth path in identity security. This article br...
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
SoFi Technologies is redefining fintech with a multi-product model that blends digital banking, lending, and crypto. ...